Friday, January 1, 2016

This new weight-loss drug is one you want to stay far away from




This new weight-loss drug is one you want to stay far away from 
Diet danger: New drug causes thyroid cancer

Dear Reader,

It looks like Big Pharma is coming at us with a double-barreled shotgun.
This month, Novo Nordisk, the company that brought us the dangerous diabetes drug Victoza, has a date with the FDA. It’s all about a deadly new way to use Victoza.

And you’ll never believe it.

Run for cover

When I read about a “new” drug the FDA is getting ready to approve, I honestly couldn’t believe my eyes.

It will be called Saxenda — and it’s the same drug already sold under the name Victoza. But just making a risky med for diabetics wasn’t enough for this maverick drug maker.

Now it wants to play a deadly deception on innocent people who are desperate to lose weight.

So what does a horrible drug aimed at diabetics have to do with a diet pill?
A lot. As in a new way to make a whole lot more money.

In a nutshell, Novo wants to take its deadly diabetes Rx and repackage it as a weight-loss drug. Its diabolical plan is to find a way to lure those who don’t even have diabetes into taking it.

I first sent you a warning about Victoza even before the FDA approved it back in 2010 for diabetics. And just this June, the group Public Citizen sent another request to the FDA asking that it be banned immediately.

Public Citizen said that Victoza “puts patients at higher risk of thyroid cancer, pancreatitis (and) serious allergic reactions.”

Now Victoza’s weight loss “secret” might have something to do with its side effects. Things like nausea, vomiting and acute diarrhea. That doesn’t do much for someone’s appetite, now does it?

Long before Victoza was approved by the FDA for type 2, Novo was secretly scheming to make this deadly twin out of it. The drug company recruited guinea pigs from around the world to “study” how much weight people could lose on Victoza.

So it’s no wonder the FDA denied Public Citizen’s petition. They knew Victoza was coming to town with a new name. So they couldn’t exactly ban the first one now, could they?

But it gets even worse…

This “new” weight loss drug comes at double the dose! And, according to Public Citizen’s research, that could mean triple the risk of pancreatitis. Of course, that didn’t stop Novo or slow down the FDA.

And Novo, which is now focusing on obesity drugs, has more than just diabetes pills to sell. And wait till you hear about the next one.

The drug maker told The Wall Street Journal that there are so many more fat people than diabetics, the market for such meds is four times the size of that for type 2 drugs! There are close to 100 million people in the U.S. it said might be candidates for this new drug.

Novo, however, has its eye on more than just that 100 million. Its first target will be those south of the border — in Mexico.

And I’m sure Novo wouldn’t mind at all if docs in this country started prescribing it “off label” for weight loss right away.

Hopefully, this horribly dangerous drug will come with the same black box warning as Victoza does about deadly thyroid tumors. And then there’s that risk of fatal pancreatitis.

As was pointed out in a Novo-funded Victoza study, “The frequency of obesity has risen dramatically in recent years but only few safe and effective drugs are currently available.”

And this sure isn’t one of them.

Novo Nordisk
In 2010 Novo Nordisk breached the ABPIs code of conduct by failing to provide information about side-effects of Victoza and by promoting Victoza prior to being granted market authorization.[21]
In 2013 Novo Nordisk had to pay back DKK 3.6 billion to the Danish tax authorities due to transfer mispricing.[22]
In March 2013, a debate emerged in which scientists questioned whether the incretin class of diabetes medications – the class to which Victoza belongs – had in increased risk of side effects in the pancreas such as pancreatitis and pancreatic cancer. It was concluded that data currently available did not confirm these concerns.[23]
In October 2013, batches of NovoMix 30 FlexPen and Penfill insulin were recalled in some European countries as their analysis had shown that a small percentage of the products in these batches did not meet the specifications for insulin strength.

Novo Nordisk
Sidley Austin LLP was the lobby firm for Novo Nordisk Inc., and is the lobby firm for the Pharmaceutical Research and Manufacturers of America (Big Pharma).

Note: Michelle Obama was a lawyer at Sidley Austin LLP.
Barack Obama was an intern at Sidley Austin LLP.
Faith Elizabeth Gay was an attorney at Sidley Austin LLP, and is a board of adviser’s member for the American Constitution Society.
Open Society Foundations was a funder for the American Constitution Society, the Atlantic Council of the United States (think tank), the Bill, Hillary & Chelsea Clinton Foundation, and the Carnegie Endowment for International Peace (think tank).
George Soros is the founder & chairman for the Open Society Foundations. 
Robert Raben was a director at the American Constitution Society, and an assistant attorney general for the U.S. Department of Justice.
David B. Barlow was the U.S. attorney for the District of Utah for the U.S. Department of Justice, and is a partner at Sidley Austin LLP.
Eric H. Holder Jr. was the attorney general at the U.S. Department of Justice for the Barack Obama administration, a board member for the American Constitution Society, is a partner at Covington & Burling LLP, and a member of the Markle Task Force on National Security in the Information Age.
Covington & Burling LLP is the lobby firm for the Pharmaceutical Research and Manufacturers of America (Big Pharma), and was the lobby firm for Novo Nordisk Inc.
Lars Rebien Sorensen is the president & CEO for Novo Nordisk Inc., and was a supervisory board member for Bertelsmann AG.
Markus Dohle is an executive board member for Bertelsmann AG, and was a director at the Atlantic Council of the United States (think tank).
Elizabeth Frawley Bagley is a director at the Atlantic Council of the United States (think tank), and was a funder for the Bill, Hillary & Chelsea Clinton Foundation.
American Cancer Society was a funder for the Bill, Hillary & Chelsea Clinton Foundation.
Margaret A. Hamburg is a member of the Markle Task Force on National Security in the Information Age, the VP for the Nuclear Threat Initiative (think tank), and was a commissioner for the U.S. Food and Drug Administration (FDA).
Jessica Tuchman Mathews is a director at the Nuclear Threat Initiative (think tank), was the president of the Carnegie Endowment for International Peace (think tank), a director at the American Friends of Bilderberg (think tank), an honorary trustee at the Brookings Institution (think tank), and a 2008 Bilderberg conference participant (think tank).
Ed Griffin’s interview with Norman Dodd in 1982
(The investigation into the Carnegie Endowment for International Peace uncovered the plans for population control by involving the United States in war)
Carnegie Endowment for International Peace (think tank) was a funder for the Nuclear Threat Initiative (think tank).      
Donald Kennedy was a trustee at the Carnegie Endowment for International Peace (think tank), and a commissioner for the U.S. Food and Drug Administration (FDA).
Open Society Foundations was a funder for the Carnegie Endowment for International Peace (think tank).
George Soros is the founder & chairman for the Open Society Foundations, and was the chairman for the Foundation to Promote Open Society.
Foundation to Promote Open Society was a funder for the Brookings Institution (think tank).  
Robert A. Helman was an honorary trustee at the Brookings Institution (think tank), and is a partner at Mayer Brown.
Mayer Brown was the lobby firm for Bertelsmann AG, and is the lobby firm for the Bayer Corporation.
Lars Rebien Sorensen was a supervisory board member for Bertelsmann AG, and is the president & CEO for Novo Nordisk Inc.
Bayer Corporation is a North American subsidiary of Bayer AG.
An aspirin a day... causes blindness?
Bayer AG - World War I and II
During World War II, IG Farben used slave labor in factories attached to large slave labor camps, notably I.G. Auschwitz,[23] and the sub-camps of the Mauthausen-Gusen concentration camp.[24] IG Farben engaged in human experimentation on Auschwitz prisoners, often with fatal results.[25] After World War II, the Allies broke up IG Farben and Bayer reappeared as an individual business. IG Farben board member Fritz ter Meer, sentenced to seven years in prison during the IG Farben Military Tribunal at Nuremberg, was elected Bayer's supervisory board head in 1956.
Bayer HealthCare is a subsidiary of Bayer AG.
Sidley Austin LLP is the lobby firm for Bayer HealthCare, the Pharmaceutical Research and Manufacturers of America (Big Pharma), and was the lobby firm for Novo Nordisk Inc.
Michelle Obama was a lawyer at Sidley Austin LLP.                    
Barack Obama was an intern at Sidley Austin LLP.

No comments: